The Western world and the big pharma are upset. They say Russia has not done adequate safety and efficacy studies and the claim is based on testing on less than 100 human volunteers

India Stock Market Highlights Today: April-June quarterly earnings announcements by Hindalco, NTPC, Glenmark Pharma, Berger Paints, United Breweries, Indian Bank, MRF, Fortis Healthcare, Greenply among others will also set the tone for the stock market today

Solutions to shadow banking risks are well-documented: tightening regulations, extending central banks' cover as lender-of-last-resort, mandating deposit insurance to prevent overnight collapse, controlling trade in highly complex, opaque and high-risk derivatives and changing short-term-funding-long-term-lending business model

That shadow banking was at the core of the financial sector meltdown that led to the Great Recession of 2007-08 is well documented and so is the fact that it remains big and powerful enough to cause serious financial crisis and yet, India and the US continue to promote it

India Stock Market Highlights Today: Bajaj Finance, followed by L&T, Bajaj Finserv, Sun Pharma, Kotak Bank, HDFC Bank and Reliance Industries were among the top losers on Sensex. On the other hand, SBI, M&M, Maruti, Bajaj Auto and Titan were among the gainers

India Stock Market Highlights Today: Axis Bank, followed by Tata Steel, ICICI Bank, HDFC, PowerGrid, Tech Mahindra and SBI were among the top gainers. On the other hand, Titan, Sun Pharma, Bharti Airtel and Reliance Industries were among the laggards

Coronavirus vaccine update: Serum Institute of India might begin its Phase 2 and 3 clinical trials in India within a week. Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate are going on in the United Kingdom, phase 3 clinical trial in Brazil

India faces a fresh threat of NPAs with RBI warning dramatic rise in loan default rate from 8.5% in FY20 to 14.7% in FY21. A global study shows the Indian corporate sector was most debt-stressed with 43% of long-term loans vulnerable to default even before the COVID-19 pandemic hit

India Stock Market Highlights Today: Kotak Bank, followed by IndusInd Bank, HDFC Bank, ONGC, PowerGrid, Axis Bank, Sun Pharma and Reliance Industries (RIL) were among the top losers today, while Bajaj Auto, Titan, Maruti, M&M and SBI were among the gainers

Global studies show ownership does not make enterprises efficient, factors like competition, autonomy, regulation and institutional development do. Evidence also shows that private sector thrives on public hand-outs in normal times and public bail-outs in crises

Apart from rise in financial frauds in private companies in India, recent years have also witnessed a rise in the role of shell companies and tax havens in their operations, raising further concerns about illicit operations

Contrary to popular belief, private sector efficiency vis-a-vis public sector is a neoliberal construct for which there is little evidence or lived experience but is pushed, nevertheless, for private gains

Saudi Arabia, the world's largest oil exporter, is facing a sharp recession because of the coronavirus crisis and depleted oil revenues

Shivinder, who is currently lodged in Tihar jail, would not walk out as he has been booked in another case of fraud by the Economic Offences Wing (EOW) in another case of fraud

Speaking about India's role in global fight against COVID-19, PM Modi said we have extended medical and other assistance to over 150 countries

If you invest in fixed rate bond at lower rate and the rate increases after some time you incur notional loss. One of the most unique advantages with this bond is that it will not carry an interest rate risk like the fixed rate bonds

For years, job crisis has remained unacknowledged and un-remedied; the COVID-19 pandemic worsened it, but the government has no information on job loss or policy response to it, except for a few relief measures

Coronavirus drug: Cipla ramps up production of antiviral remdesivir amid demand spurtIn wake of rising demand for antiviral drug Remdesivir used for coronavirus treatment, homegrown drug major Cipla has ramped up its capacity and that of its partner network to fill the demand-supply gap. Last month, the company launched the generic version of Gilead Sciences' antiviral drug Remdesivir under its brand name 'CIPREMI'.Indian IT firms' revenues may contract up to 3% in FY21, says ICRAThe India...

Of the 147 intimations received till date, claim documents have been submitted for 87, out of which 15 have been paid, 4 approved for payment while 13 are under examination

Coronavirus crisis: The AIMED said that with no order from the government, manufacturers do not only have unsold inventory but are also witnessing falling demand and crashing prices